How to buy Avid Bioservices stock | $21.28

Avid Bioservices, Inc is a biotechnology business based in the US. Avid Bioservices shares (CDMO) are listed on the NASDAQ and all prices are listed in US Dollars. Avid Bioservices employs 252 staff and has a trailing 12-month revenue of around 0.00.

Avid Bioservices stock price (NASDAQ: CDMO)

Use our graph to track the performance of CDMO stocks over time.

Avid Bioservices shares at a glance

• Key figures

Information last updated 2021-07-28.

Latest market close	$21.28
52-week range	$6.61 - $27.02
50-day moving average	$24.88
200-day moving average	$20.14
Wall St. target price	$28.25
PE ratio	461.0526
Dividend yield	N/A (0%)
Earnings per share (TTM)	$0.06

Buy Avid Bioservices shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Avid Bioservices stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Avid Bioservices, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Avid Bioservices price performance over time

Historical closes compared with the close of $21.28 from 2021-05-28

1 week (2021-07-21)	N/A
1 month (2021-07-01)	-19.88%
3 months (2021-04-30)	-0.61%
6 months (2021-01-28)	N/A

1 year (2020-07-28)	N/A
2 years (2019-07-28)	N/A
3 years (2018-07-28)	N/A
5 years (2016-07-28)	N/A

Is Avid Bioservices under- or over-valued?

Valuing Avid Bioservices stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Avid Bioservices's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Avid Bioservices's P/E ratio

Avid Bioservices's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 461x. In other words, Avid Bioservices shares trade at around 461x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Avid Bioservices's EBITDA

Avid Bioservices's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $15.7 million.

The EBITDA is a measure of a Avid Bioservices's overall financial performance and is widely used to measure a its profitability.

Avid Bioservices financials

Revenue TTM	$95.9 million
Operating margin TTM	12.77%
Gross profit TTM	$29.3 million
Return on assets TTM	4.1%
Return on equity TTM	18.74%
Profit margin	11.7%
Book value	$1.27
Market capitalisation	$1.6 billion

TTM: trailing 12 months

Shorting Avid Bioservices shares

There are currently 4.9 million Avid Bioservices shares held short by investors – that's known as Avid Bioservices's "short interest". This figure is 0.9% up from 4.8 million last month.

There are a few different ways that this level of interest in shorting Avid Bioservices shares can be evaluated.

Avid Bioservices's "short interest ratio" (SIR)

Avid Bioservices's "short interest ratio" (SIR) is the quantity of Avid Bioservices shares currently shorted divided by the average quantity of Avid Bioservices shares traded daily (recently around 808537.85123967). Avid Bioservices's SIR currently stands at 6.05. In other words for every 100,000 Avid Bioservices shares traded daily on the market, roughly 6050 shares are currently held short.

However Avid Bioservices's short interest can also be evaluated against the total number of Avid Bioservices shares, or, against the total number of tradable Avid Bioservices shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Avid Bioservices's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Avid Bioservices shares in existence, roughly 80 shares are currently held short) or 0.0874% of the tradable shares (for every 100,000 tradable Avid Bioservices shares, roughly 87 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Avid Bioservices.

Find out more about how you can short Avid Bioservices stock.

Avid Bioservices share dividends

We're not expecting Avid Bioservices to pay a dividend over the next 12 months.

Have Avid Bioservices's shares ever split?

Avid Bioservices's shares were split on a 1:7 basis on 9 July 2017. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Avid Bioservices shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Avid Bioservices shares which in turn could have impacted Avid Bioservices's share price.

Avid Bioservices share price volatility

Over the last 12 months, Avid Bioservices's shares have ranged in value from as little as $6.61 up to $27.02. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Avid Bioservices's is 2.2165. This would suggest that Avid Bioservices's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Avid Bioservices overview

Avid Bioservices, Inc. , a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. It produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. The company also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. It serves biotechnology and pharmaceutical companies. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc.

Frequently asked questions

What percentage of Avid Bioservices is owned by insiders or institutions?
Currently 1.602% of Avid Bioservices shares are held by insiders and 86.81% by institutions. How many people work for Avid Bioservices?
Latest data suggests 252 work at Avid Bioservices. When does the fiscal year end for Avid Bioservices?
Avid Bioservices's fiscal year ends in April. Where is Avid Bioservices based?
Avid Bioservices's address is: 2642 Michelle Drive, Tustin, CA, United States, 92780 What is Avid Bioservices's ISIN number?
Avid Bioservices's international securities identification number is: US05368M1062 What is Avid Bioservices's CUSIP number?
Avid Bioservices's Committee on Uniform Securities Identification Procedures number is: 05368M106